303 related articles for article (PubMed ID: 8869754)
1. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
Kido H; Niwa Y; Beppu Y; Towatari T
Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
[TBL] [Abstract][Full Text] [Related]
2. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
[TBL] [Abstract][Full Text] [Related]
3. Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses.
Kido H; Murakami M; Oba K; Chen Y; Towatari T
Mol Cells; 1999 Jun; 9(3):235-44. PubMed ID: 10420980
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of proteolytic activation of Sendai virus infection and the defensive compounds for infection.
Kido H; Beppu Y; Sakai K; Towatari T
Biol Chem; 1997; 378(3-4):255-63. PubMed ID: 9165079
[TBL] [Abstract][Full Text] [Related]
5. Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses.
Beppu Y; Imamura Y; Tashiro M; Towatari T; Ariga H; Kido H
J Biochem; 1997 Feb; 121(2):309-16. PubMed ID: 9089405
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus.
Kido H; Sakai K; Kishino Y; Tashiro M
FEBS Lett; 1993 May; 322(2):115-9. PubMed ID: 8387030
[TBL] [Abstract][Full Text] [Related]
7. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tryptase TL2 from human T4+ lymphocytes and inhibition of HIV-1 replication in H9 cells by recombinant aprotinin and bikunin homologues.
Brinkmann T; Schäfers J; Gürtler L; Kido H; Niwa Y; Katunuma N; Tschesche H
J Protein Chem; 1997 Aug; 16(6):651-60. PubMed ID: 9263127
[TBL] [Abstract][Full Text] [Related]
9. Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp 120.
Kido H; Fukutomi A; Katunuma N
FEBS Lett; 1991 Jul; 286(1-2):233-6. PubMed ID: 1677898
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein.
Kido H; Yokogoshi Y; Sakai K; Tashiro M; Kishino Y; Fukutomi A; Katunuma N
J Biol Chem; 1992 Jul; 267(19):13573-9. PubMed ID: 1618859
[TBL] [Abstract][Full Text] [Related]
11. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
Clements GJ; Price-Jones MJ; Stephens PE; Sutton C; Schulz TF; Clapham PR; McKeating JA; McClure MO; Thomson S; Marsh M
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):3-16. PubMed ID: 2015114
[TBL] [Abstract][Full Text] [Related]
12. Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein.
Harvima IT; Harvima RJ; Nilsson G; Ivanoff L; Schwartz LB
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):711-8. PubMed ID: 8318003
[TBL] [Abstract][Full Text] [Related]
13. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.
Tashiro M; Yokogoshi Y; Tobita K; Seto JT; Rott R; Kido H
J Virol; 1992 Dec; 66(12):7211-6. PubMed ID: 1331518
[TBL] [Abstract][Full Text] [Related]
14. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization.
Chen Y; Shiota M; Ohuchi M; Towatari T; Tashiro J; Murakami M; Yano M; Yang B; Kido H
Eur J Biochem; 2000 Jun; 267(11):3189-97. PubMed ID: 10824103
[TBL] [Abstract][Full Text] [Related]
15. Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus.
Murakami M; Towatari T; Ohuchi M; Shiota M; Akao M; Okumura Y; Parry MA; Kido H
Eur J Biochem; 2001 May; 268(10):2847-55. PubMed ID: 11358500
[TBL] [Abstract][Full Text] [Related]
16. Sendai virus infection changes the subcellular localization of tryptase Clara in rat bronchiolar epithelial cells.
Sakai K; Kohri T; Tashiro M; Kishino Y; Kido H
Eur Respir J; 1994 Apr; 7(4):686-92. PubMed ID: 8005249
[TBL] [Abstract][Full Text] [Related]
17. A novel influenza A virus activating enzyme from porcine lung: purification and characterization.
Sato M; Yoshida S; Iida K; Tomozawa T; Kido H; Yamashita M
Biol Chem; 2003 Feb; 384(2):219-27. PubMed ID: 12675514
[TBL] [Abstract][Full Text] [Related]
18. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
Sattentau QJ; Moore JP
J Exp Med; 1991 Aug; 174(2):407-15. PubMed ID: 1713252
[TBL] [Abstract][Full Text] [Related]
19. Maturation of HIV envelope glycoprotein precursors by cellular endoproteases.
Moulard M; Decroly E
Biochim Biophys Acta; 2000 Nov; 1469(3):121-32. PubMed ID: 11063880
[TBL] [Abstract][Full Text] [Related]
20. Interaction between a membrane-associated serine proteinase of U-937 monocytes and peptides from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein.
Avril LE; Di Martino-Ferrer M; Barin F; Gauthier F
FEBS Lett; 1993 Feb; 317(1-2):167-72. PubMed ID: 8428626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]